Your Patient’s Health Should Supplant ‘Public’ Health
The COVID-19 crisis has revealed foundational flaws in our medical system. Starting with the government’s further intrusion into your medical care with the affordable care act in 2010 and stretching across the horror show of the last two years, the doctor-patient relationship that the typical American relies on for care changed without their knowledge or consent.
Where did your trusted doctor go? Dr. Jordan Vaughn and Dr. Stewart Tankersley pose the question everyone has been asking after the last two years of madness… Starting with this question, they examine the problem and the current crisis and discuss possible solutions to explore in the coming months.
Your physician’s name and location may not have changed, but the doctor’s freedom to treat you as a unique individual and advocate for your best interests did change.
In a society of leaders who continue to break their oaths to the citizens ⏤ having such a personal oath between a physician and patient compromised is a worrisome sign and, unfortunately, with deadly consequences. Our academic and corporate medical leaders were more concerned about the hospitals surviving this pandemic than the patients these systems serve.
In the end, the hospitals survived, but the patients did not.
If the foundation of medicine is the oath to care for the patient and do no harm, how did the most significant medical crisis in our country in one hundred years result in the medical profession tacitly abandoning the sick and causing immense damage?
More Stories
Concerned Doctors with Dr. Albert Benavides
https://rumble.com/embed/v1ipffl/?pub=r2wmz Click Here to Enter Albert Benavides Dashboard
WHO HANDED THE KEYS TO FAUCI?!
https://www.bitchute.com/video/w2pPTZ67ikHH/ The Highwire with Del Bigtree The Highwire with Del Bigtree
SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factos in Human Lung Microvascular Endothelial Cell and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenisis
In SARS-CoV-2-infected humans, disease progression is often associated with acute respiratory distress syndrome involving severe lung injury, coagulopathy, and thrombosis of the alveolar capillaries. The pathogenesis of these pulmonary complications in COVID-19 patients has not been elucidated. Autopsy study of these patients showed SARS-CoV-2 virions in pulmonary vessels and sequestrated leukocytes infiltrates associated with endotheliopathy and microvascular thrombosis. Since SARS-CoV-2 enters and infects target cells by binding its spike (S) protein to cellular angiotensin-converting enzyme 2 (ACE2), and there is evidence that vascular endothelial cells and neutrophils express ACE2, we investigated the effect of S-proteins and cell–cell communication on primary human lung microvascular endothelial cells (HLMEC) and neutrophils expression of thrombogenic factors and the potential mechanisms. Using S-proteins of two different SARS-CoV-2 variants (Wuhan and Delta), we demonstrate that exposure of HLMEC or neutrophils to S-proteins, co-culture of HLMEC exposed to S-proteins with non-exposed neutrophils, or co-culture of neutrophils exposed to S-proteins with non-exposed HLMEC induced transcriptional upregulation of tissue factor (TF), significantly increased the expression and secretion of factor (F)-V, thrombin, and fibrinogen and inhibited tissue factor pathway inhibitor (TFPI), the primary regulator of the extrinsic pathway of blood coagulation, in both cell types. Recombinant (r)TFPI and a thiol blocker (5,5′-dithio-bis-(2-nitrobenzoic acid)) prevented S-protein-induced expression and secretion of Factor-V, thrombin, and fibrinogen. Thrombomodulin blocked S-protein-induced expression and secretion of fibrinogen but had no effect on S-protein-induced expression of Factor-V or thrombin. These results suggests that following SARS-CoV-2 contact with the pulmonary endothelium or neutrophils and endothelial–neutrophil interactions, viral S-proteins induce coagulopathy via the TF pathway and mechanisms involving functional thiol groups. These findings suggest that using rTFPI and/or thiol-based drugs could be a viable therapeutic strategy against SARS-CoV-2-induced coagulopathy and thrombosis. View Full-Text
Oro-Systemic Health Symposium 2022 – Part 3: Graham Lloyd-Jones – The anatomy of COVID-19
https://youtu.be/pPsbO1Qw2GM Dr. Graham Lloyd-Jones, Consultant Radiologist at Salisbury NHS Foundation Trust and Director of Radiology Masterclass, describes the nature of...